|

Lupron Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Leuprolide

Pipeline

Phase 2: 1

Top Sponsors

  • Icahn School of Medicine at Mount Sinai1

Indications

  • High Risk Prostate Cancer1
  • Prostate Cancer1
  • Cancer1

New York, New York1 trial

Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer

Icahn School of Medicine at Mount Sinai

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.